Le Lézard
Classified in: Health
Subjects: SVY, PET, ANW

Global Veterinary Diagnostic Testing for Pets and Animals Will Grow to $5.8 Billion in 2027

"The World Market for Veterinary Diagnostics, 6th Edition" is the latest market research report from Kalorama Information.

ARLINGTON, Va., Feb. 23, 2023 /PRNewswire-PRWeb/ -- Where the pets go, so go the profits. This is true not just for mainstream pet products (such as food and toys) or services (such as grooming and boarding), but extends to veterinary pet healthcare, most notably veterinary diagnostic testing. Indeed, the global veterinary diagnostic market is forecast to grow to approximately $5.8 billion in 2027, according to The World Market for Veterinary Diagnostics, 6th Edition, the latest report by market research firm Kalorama Information.

The veterinary diagnostics market is best characterized preliminarily through its two primary segments: companion animal (pets such as dogs and cats and domestic animals including horses) and food animal (livestock and production animal) diagnostics. The two segments differ significantly in terms of demand, drivers and primary product groups. Infectious disease is a significant component in the veterinary care of companion animals, though improving standards and levels of consumer spending on companion animal care produce a much larger market for laboratory analyzers used for non-infectious disease or general health testing. Food animal diagnostics is led foremost by infectious disease assays in various forms described in this section.

"Diagnostic testing is an important aspect of animal healthcare. There is a wide variety of tests available for veterinarians to use to identify and monitor diseases," says Bruce Carlson, publisher for Kalorama Information.

Veterinary diagnostic testing is becoming more mainstream as consumers embrace advanced pet healthcare. Diagnostic testing has become more sophisticated in the last several years benefiting from advancements in technology and accuracy. Testing has become a mainstay in the practice of veterinary medicine and has proven to be vital for the safety of food animals and well-being of companion animals. In vitro diagnostic (IVD) instrumentation and products have been extensively applied to veterinary healthcare; various assay forms, analytes and analyzers are transferrable from the clinical space to the veterinary clinic and laboratory.

Veterinary diagnostics comprehensively support animal health:

International trade, public health, agricultural productivity, consumer confidence and companion animal-owner relationships are all dependent upon effective and increasingly specialized veterinary diagnostics products. Expertise in molecular diagnostics, virology and bacteriology is crucial in the food animal (livestock and production animal) diagnostics space as emergent threats and outbreaks necessitate the development and improvement of assays for newly implemented disease control programs. Technical barriers to entry in the lucrative companion animal diagnostics space are relatively low. Many market participants in companion animal diagnostics have adapted clinical diagnostic analyzers?hematology analyzers or blood counters, chemistry analyzers, critical care analyzers?with modifications limited mostly to reference ranges, sample preparation and some parameters.


The World Market for Veterinary Diagnostics, 6th Edition examines the worldwide veterinary diagnostics market through the performance of its two component markets of companion animal (pets) and food animal diagnostics. The report provides analysis of major veterinary disease markets as well as overall market performance and development.

For more information or to purchase the market research report "The World Market for Veterinary Diagnostics, 6th Edition," visit: https://kaloramainformation.com/product/veterinary-diagnostics-dogs-cats-horses-pets/.


Kalorama Information, part of Science and Medicine Group, is the leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, medical devices, and pharmaceuticals. Science and Medicine Group supports companies seeking to commercialize the rapidly changing marketplace at the intersection of science, medicine, and technology. Comprised of industry-leading brands, Science and Medicine Group serves analytical instrument, life science, imaging, and clinical diagnostic companies by helping them create strategies and products to win markets and provide platforms to digitally engage their markets through a variety of innovative solutions. Kalorama Information produces 30 reports a year. The firm offers a Knowledge Center, which provides access to all published reports.

Media Contact

DANIEL GRANDERSON, Kalorama Information, (703) 783-1721, daniel.granderson@scienceandmedicinegroup.com


SOURCE Kalorama Information

These press releases may also interest you

at 12:05
New data released today at the American Society of Clinical Oncology (ASCO) Annual Meeting highlighted the application of PathomIQ Inc.'s PATHOMIQ_PRAD AI test to assess the risk for metastasis in non-metastatic castration-resistant prostate cancer...

at 12:00
The global active pharmaceutical ingredients and high potency API industry size stood at USD 233.31 billion in 2021 and is poised to observe a CAGR of 6% from 2022 to 2030, according to the "Active Pharmaceutical Ingredients and High Potency API...

at 12:00
OpenBench, Inc., a pioneer in success-driven small molecule discovery collaborations, today announced the launch of a collaboration with Related Sciences ("RS"), a data science-driven drug discovery studio, to leverage OpenBench's structure-based...

at 12:00
MedVanta, the nation's largest physician-owned and led musculoskeletal management services organization (MSO), today announced the appointment of its first Chief Information Officer, Tony Yi, as well as Christine DeAngelis, Senior Vice President,...

at 12:00
Body-obsessed individuals are being overwhelmed by images of Kardashian glutes and top influencers' magic fat-burning posts. The Internet and social media posts are ripe with the promise of quick weight loss by injecting Semaglutide. The global surge...

at 12:00
A news report from Daily Mail Pakistan: In the fight against the COVID-19 pandemic, one healthcare expert has emerged as a leading authority: Dr.Umar Saeed. With an impressive academic background and extensive experience in infectious diseases,...

News published on and distributed by: